CANbridge Pharmaceuticals Ltd Listed on Main Board of Hong Kong Stock Exchange
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 9, 2021--
Stay updated with breaking news from Planet Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 9, 2021--
Press release content from Business Wire. The AP news staff was not involved in its creation.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Press release content from Business Wire. The AP news staff was not involved in its creation. CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration February 25, 2021 GMT BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 25, 2021-- CANbridge Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing drug candidates in China and North Asia, and Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, have agreed to terminate their 2018 license agreement, in which Puma granted CANbridge...